AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2013
May 15, 2013
30339_dirs_2013-05-15_e313f1f9-84b7-4f31-86bf-fc8fff1f637e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-02-19
Reporting Person: Lennartz Heino (President Europe)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-02-19 | Common Stock | A | 2661.0000 | $59.1100 | Acquired | 7090.1040 | Direct |
Footnotes
F1: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2010 that have vested for performance period 9.
F2: Amended Form 4 to account for taxes withheld from original share acquisition number which was not provided when original Form 4 was filed. Original number of 4,778 shares now reflects the tax withholding of 2,117 shares for a total acquisition of 2,661 shares.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27